The fifth protease inhibitor, Agenerase (amprenavir)
May 2001
The fifth protease inhibitor, Agenerase (amprenavir), will soon hit the market...from GlaxoSmithKline.
It will be used in combo therapy with other HIV antiretrovirals.
The usual adult dose is 1200 mg (8 capsules) BID.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote